Safety and Tolerability of an SQ-Standardized GRAss ALlergy Immunotherapy Tablet (GRAZAX®) in a Real-Life Setting for Three Consecutive Seasons - The GRAAL Trial

Author: Wessel François   Chartier Antoine  

Publisher: Adis International

ISSN: 1173-2563

Source: Clinical Drug Investigation, Vol.32, Iss.7, 2012-07, pp. : 451-463

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content